Reclutamiento
Quiénes somos
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
A Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
MAQ-001 in Patients With Advanced Solid Tumors
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
